Ganapathy Subramanian, Ranjani
Zivadinov, Robert
Bergsland, Niels
Dwyer, Michael G.
Weinstock-Guttman, Bianca
Jakimovski, Dejan http://orcid.org/0000-0001-7114-4958
Article History
Received: 17 February 2023
Revised: 31 March 2023
Accepted: 5 April 2023
First Online: 17 April 2023
Declarations
:
: Ranjani Ganapathy and Niels Bergsland have nothing to disclose. Michael G. Dwyer received personal compensation from Keystone Heart for speaking and consultant fees. He received financial support for research activities from Bristol Myers Squibb, Novartis and Keystone Heart. Bianca Weinstock-Guttman has participated in speaker’s bureaus and/or served as a consultant for Biogen, Novartis, Genzyme & Sanofi, Genentech, Abbvie, Bayer AG, and Celgene/ BMS. Dr. Weinstock-Guttman also has received grant/research support from the agencies listed in the previous sentence as well as Mallinckrodt Pharmaceuticals, Inc. She serves in the editorial board for BMJ Neurology, Journal of International MS and CNS Drugs. Robert Zivadinov received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Novartis and Keystone Heart for speaking and consultant fees. He received financial support for research activities from Bristol Myers Squibb, Sanofi, Novartis, Keystone Heart, V-WAVE Medical, Mapi Pharma and Protembis. Dejan Jakimovski serves as Associate Editor of Clinical Neurology and Neurosurgery and compensated by Elsevier B.V. The study has been approved by the appropriate ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The specific national laws have been observed.